LONDON, December 17 /PRNewswire/ -- With the vast majority of our efforts focused squarely on the sales force, e-marketing is still an add-on, says Martin Hensen, head of e-strategies, UCB Germany. But successful e-CRM strategies are the basic starting point for all e-activities, he told eyeforpharma.
To view the Multimedia News Release, please click:
For the sales force, CRM strategies build targeting and steering, as well as customer classification to personalise and individualise marketing efforts. And such customisation, Hensen says, reminds him of social media. But he questions whether pharma is ready to engage with Web 2.0.
The health system is 100% regulated, Hensen says, making it Health 1.0. But pharma itself is no better. He says with content needing 100% approval, social media tools like YouTube and Facebook are blocked at many healthcare companies, more SOPs than websites and more people in Legal than in e-Business, pharma companies themselves are still at Pharma 1.0. And it's strictly Product managers 1.0, Hensen says, considering that most have only sales force, not internet, experience.
SFE Europe 2010, 27-29th April, Barcelona, addresses these issues head-on and presents best practices in meeting these challenges. A particular highlight will be Charlotte Sibley, SVP, Shire, Janssen Cilag discussing 'New Customers, New Influencers and New Regulations: How do you change your activities to engage customers?'
For more information visit http://www.eyeforpharma.com/sales
Key note speakers include: - Tyrone Edwards, SVP, Merck Co (ret.) - Eric Rambeaux, VP, Solvay - Veronique Toully, VP, UCB - Charlotte Sibley, SVP, Shire For the full speaker line up and presentation content visit: http://www.eyeforpharma.com/sales/brochure.php Media contact Kate Eversole VP Europe eyeforpharma T: +44(0)207-375-7594 E: firstname.lastname@example.org
CONTACT: Media contact: Kate Eversole, VP Europe, eyeforpharma, T:+44(0)207-375-7594, E: email@example.com